Charles River Laboratories International Inc
Charles River Laboratories International Inc is a Life Sciences Tools & Services company listed on NEW YORK STOCK EXCHANGE, INC..
Industry
Life Sciences Tools & Services
Exchange
NEW YORK STOCK EXCHANGE, INC.
Market Cap
$13.3B
P/E Ratio
—
Cash on Hand
$209M(positive)
Shares Outstanding
48.2M shares
Currency
USD
Earnings (EPS)
QuarterEPS EstimateEPS Actual
Q2 2026$2.76$3.02
Q1 2026$1.96$2.06
Q4 2025$2.37$2.39
Q3 2025$2.36$2.43
Financial Highlights
The basics, explained simply — no finance degree required.
52-Week Range
$144.26 – $303.31
The lowest and highest price this stock has traded at over the past year.
Profit Margin
-6.0%
How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.
Revenue Growth
-0.7%
How much the company's sales grew compared to a year ago.
Volatility (Beta)
1.41
How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.
Analyst Insights
Insider Activity
Recent buys and sells by company executives and directors — publicly disclosed, as required by law.
FOSTER JAMES C
Aug 25, 2026 • $194.12/share
Bought 21,132
FOSTER JAMES C
Aug 25, 2026 • $208.44/share
Bought 12,429
FOSTER JAMES C
Aug 25, 2026 • $300.00/share
Sold 33,561
FOSTER JAMES C
Aug 25, 2026
Sold 21,132
FOSTER JAMES C
Aug 25, 2026
Sold 12,429
Parisotto Shannon M
Aug 11, 2026 • $179.66/share
Bought 3,714
Recent News
Are Medical Stocks Lagging Amgen (AMGN) This Year?
Yahoo • Sep 11
Charles River Laboratories to Present at Morgan Stanley and Baird Conferences
Yahoo • Sep 11
Evercore ISI Group Maintains Outperform on Charles River, Raises Price Target to $320
Benzinga • Sep 11
Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite
Yahoo • Sep 8
Health Care's Next Act: Tailwinds Emerging Across R&D Cycle
SeekingAlpha • Sep 8